Real-time enrollment status for this basal cell carcinoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06344052 |
| Recruiting Status | Recruiting |
| Condition | Basal Cell Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Stamford Pharmaceuticals, Inc. |
| Last Updated on CT.gov | September 20, 2024 (Sep 20, 2024) |
As of March 2, 2026: Clinical trial NCT06344052 is currently recruiting participants. This clinical trial study for basal cell carcinoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Stamford Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06344052 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06344052 was last updated Sep 20, 2024 (September 20, 2024). HelloStudys verifies this status automatically.